{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q99835",
      "entity_text" : "SMO",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:24776445",
      "entity_text" : "Vismodegib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Vismodegib (GDC-0449), a small-molecule Hh inhibitor has been shown to reduce desmoplasia by targeting smoothened (SMO) receptor, and significantly improves the intra-tumoral concentration of anticancer agents XREF_BIBR.",
  "reading_complete" : "2020-08-02T15:58:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T15:55:48Z",
  "trigger" : "reduce",
  "evidence" : [ "Vismodegib (GDC-0449), a small-molecule Hh inhibitor has been shown to reduce desmoplasia by targeting smoothened (SMO" ],
  "pmc_id" : "6096395",
  "score" : 0
}